RAB20

Chr 13

RAB20, member RAS oncogene family

RAB20 encodes a small GTPase that regulates intracellular membrane trafficking, specifically controlling apical endocytosis, phagosome maturation and acidification, and phagosome-lysosome fusion. The gene shows low constraint to loss-of-function variation (pLI = 0.004, LOEUF = 1.6), but no confirmed disease associations have been established in humans. Currently, mutations in RAB20 have not been definitively linked to any recognized genetic disorders.

Summary from RefSeq, UniProt
Research Assistant →
0
Active trials
4
Pubs (1 yr)
111
P/LP submissions
0%
P/LP missense
1.60
LOEUF
Multiple*
Mechanism· predicted
Clinical SummaryRAB20
Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
111 unique Pathogenic / Likely Pathogenic· 56 VUS of 170 total submissions
Some data sources returned errors (1)

pubtator: TimeoutError: The operation was aborted due to timeout

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint
1.60LOEUF
pLI 0.004
Z-score 0.58
OE 0.73 (0.361.60)
Tolerant

Highly tolerant — LoF variants common in population

Missense Constraint
0.70Z-score
OE missense 0.84 (0.720.97)
118 obs / 141.3 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios
LoF OE0.73 (0.361.60)
00.351.4
Missense OE0.84 (0.720.97)
00.61.4
Synonymous OE0.93
01.21.6
LoF obs/exp: 4 / 5.5Missense obs/exp: 118 / 141.3Syn Z: 0.43
DN
0.79top 25%
GOF
0.76top 25%
LOF
0.2386th %ile

This gene has evidence for multiple mechanisms of pathogenicity (dominant-negative and gain-of-function). Both the Badonyi & Marsh prediction and the broader genomic evidence point to dominant-negative as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

DNprediction above median
GOFprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

170 submitted variants in ClinVar

Classification Summary

Pathogenic110
Likely Pathogenic1
VUS56
Likely Benign1
110
Pathogenic
1
Likely Pathogenic
56
VUS
1
Likely Benign

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
0
0
110
0
110
Likely Pathogenic
0
0
1
0
1
VUS
0
37
19
0
56
Likely Benign
0
1
0
0
1
Benign
0
0
0
0
0
Total0381300168

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

RAB20 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →